Relay Therapeutics, Inc.
SEC CIK 1812364 · RLAY · last insider filing 2026-06-24
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Hill Linda A | Director | filed 2020 - 2026 |
| Ingram Douglas S | Director | filed 2020 - 2026 |
| Borisy Alexis | Director | filed 2020 - 2026 |
| Coats Lonnel | Director | filed 2025 - 2026 |
| Dable Habib J | Director | filed 2025 - 2026 |
| Murcko Mark | Director | filed 2020 - 2026 |
| Mazumdar Claire | Director | filed 2025 - 2026 |
| Patel Sanjiv | Director · President and CEO | filed 2020 - 2026 |
| Rubin Jami | Director | filed 2020 - 2025 |
| Kathiresan Sekar | Director | filed 2022 - 2025 |
| Shawver Laura | Director | filed 2020 - 2024 |
| Nishar Dipchand | Director | filed 2020 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Bergstrom Donald A | See Remarks | filed 2020 - 2026 |
| Catinazzo Thomas | Vice President, Finance | filed 2020 - 2026 |
| Rahmer Peter | See remarks | filed 2023 - 2026 |
| Adams Brian | General Counsel | filed 2020 - 2025 |
| Porter Andy | See Remarks | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.